Drug profile · INN
eribulin mesilate
HALAVEN INITIAL APPROVAL
- Patents linked
- 0
- News articles
- 0
Quick answer
eribulin mesilate (HALAVEN INITIAL APPROVAL) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN eribulin mesilate
Brand HALAVEN INITIAL APPROVAL
Frequently asked questions
What is eribulin mesilate?
eribulin mesilate (HALAVEN INITIAL APPROVAL) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for eribulin mesilate?
HALAVEN INITIAL APPROVAL is a marketed brand name for eribulin mesilate. Check FDA Drugs@FDA for the current US label holder and prescribing information.